Normalized median fluorescence: an alternative flow cytometry analysis method for tracking human embryonic stem cell...

Area of Science:

• Stem Cell Biology
• Biotechnology
• Immunology

Background:

• Human embryonic stem cells (hESCs) are vital for tissue engineering and regenerative medicine.
• Accurate identification of hESC state and progeny is crucial for therapeutic applications.
• Flow cytometry is a common method for hESC identification using antibody-based antigen detection.

Purpose of the Study:

• To introduce and validate normalized median fluorescence intensity (nMFI) as a superior reporting metric for flow cytometry analysis of hESCs.
• To demonstrate the advantages of nMFI over the traditional percentage of positive cells (%Pos) reporting method.
• To assess the sensitivity of nMFI in detecting expression changes during hESC differentiation.

Main Methods:

• Utilized flow cytometry for hESC analysis.
• Compared the traditional %Pos reporting method with the proposed nMFI metric.
• Normalized median fluorescence intensity (MFI) of stained samples to the MFI of negative controls.
• Evaluated nMFI's accuracy in representing cell population quality and inter-experimental run comparisons.
• Assessed nMFI's sensitivity in tracking pluripotent and differentiation marker expression during hESC differentiation into three germ layer lineages.

Main Results:

• The %Pos metric is susceptible to outlier distortion and information loss regarding fluorescence intensity.
• nMFI provides a more accurate representation of starting cell population quality.
• nMFI facilitates more reliable comparisons of data across different experimental runs.
• nMFI proved to be a more sensitive measure for detecting expression changes in pluripotent and differentiation markers during hESC differentiation.

Conclusions:

• Normalized median fluorescence intensity (nMFI) is a more accurate and sensitive reporting metric for flow cytometry analysis of hESCs compared to %Pos.
• nMFI enhances the reliability of hESC characterization and monitoring of differentiation processes.
• This improved methodology supports advancements in hESC-based tissue engineering and regenerative medicine.